Your shopping cart is currently empty

LSD acetate is a polypeptide that specifically targets C8161 melanoma lymphatic vessels without binding to normal lymphatic vessels or tumor blood vessels. When conjugated with pro-apoptotic peptides, LSD acetate can reduce the number of tumor lymphatic vessels. It is useful in research focused on targeted therapy and diagnostics for tumor lymphatic vessels.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | LSD acetate is a polypeptide that specifically targets C8161 melanoma lymphatic vessels without binding to normal lymphatic vessels or tumor blood vessels. When conjugated with pro-apoptotic peptides, LSD acetate can reduce the number of tumor lymphatic vessels. It is useful in research focused on targeted therapy and diagnostics for tumor lymphatic vessels. |
| Sequence | Cys-Leu-Ser-Asp-Gly-Lys-Arg-Lys-Cys |
| Sequence Short | CLSDGKRKC |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.